Drug search by name
Daclizumab Subcutaneous and Mogamulizumab
Determining the interaction of Daclizumab Subcutaneous and Mogamulizumab and the possibility of their joint administration.
Check result:
Daclizumab Subcutaneous <> Mogamulizumab
Relevance: 11.12.2022
Reviewer: Shkutko P.M., M.D., in
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Daclizumab Subcutaneous
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Mogamulizumab
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
The list of popular interactions
- Daclizumab Subcutaneous-Mogamulizumab-kpkc
- Daclizumab Subcutaneous-Mogamulizumab-kpkc Intravenous
- Daclizumab Subcutaneous-Molindone
- Daclizumab Subcutaneous-Mometasone (Oral Inhalation)
- Daclizumab Subcutaneous-Mometasone and Formoterol
- Daclizumab Subcutaneous-Mometasone and formoterol Inhalation
- Mogamulizumab-Dacogen
- Mogamulizumab-Dacomitinib
- Mogamulizumab-Dactinomycin
- Mogamulizumab-Dactinomycin Injection
- Mogamulizumab-Dactinomycin Intravenous
- Mogamulizumab-Daklinza
Doktika World
Interaction with food and lifestyle
Disease interaction